ReproCELL Incorporated (TYO:4978)

ReproCELL Statistics

Total Valuation

ReproCELL has a market cap or net worth of JPY 17.33 billion. The enterprise value is 10.48 billion.

Market Cap	17.33B
Enterprise Value	10.48B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

ReproCELL has 94.69 million shares outstanding. The number of shares has increased by 3.91% in one year.

Current Share Class	94.69M
Shares Outstanding	94.69M
Shares Change (YoY)	+3.91%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.22%
Owned by Institutions (%)	1.11%
Float	91.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.88
PB Ratio	1.97
P/TBV Ratio	1.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-32.34
EV / Sales	4.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.12

Current Ratio	5.12
Quick Ratio	4.80
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.67% and return on invested capital (ROIC) is -4.43%.

Return on Equity (ROE)	-3.67%
Return on Assets (ROA)	-3.62%
Return on Invested Capital (ROIC)	-4.43%
Return on Capital Employed (ROCE)	-7.03%
Weighted Average Cost of Capital (WACC)	7.72%
Revenue Per Employee	25.44M
Profits Per Employee	-3.27M
Employee Count	99
Asset Turnover	0.23
Inventory Turnover	4.15

Taxes

Income Tax	-53.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.40% in the last 52 weeks. The beta is 0.63, so ReproCELL's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+20.40%
50-Day Moving Average	170.22
200-Day Moving Average	177.96
Relative Strength Index (RSI)	55.81
Average Volume (20 Days)	1,187,780

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ReproCELL had revenue of JPY 2.52 billion and -324.00 million in losses. Loss per share was -3.42.

Revenue	2.52B
Gross Profit	1.24B
Operating Income	-627.00M
Pretax Income	-377.00M
Net Income	-324.00M
EBITDA	-568.25M
EBIT	-627.00M
Loss Per Share	-3.42

Balance Sheet

The company has 6.85 billion in cash and n/a in debt, with a net cash position of 6.85 billion or 72.32 per share.

Cash & Cash Equivalents	6.85B
Total Debt	n/a
Net Cash	6.85B
Net Cash Per Share	72.32
Equity (Book Value)	8.79B
Book Value Per Share	92.81
Working Capital	6.13B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	58.75M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 49.31%, with operating and profit margins of -24.89% and -12.86%.

Gross Margin	49.31%
Operating Margin	-24.89%
Pretax Margin	-14.97%
Profit Margin	-12.86%
EBITDA Margin	-22.56%
EBIT Margin	-24.89%
FCF Margin	n/a

Dividends & Yields

ReproCELL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.91%
Shareholder Yield	-3.91%
Earnings Yield	-1.87%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 28, 2013. It was a forward split with a ratio of 5.

Last Split Date	Aug 28, 2013
Split Type	Forward
Split Ratio	5

Scores

ReproCELL has an Altman Z-Score of 6.6 and a Piotroski F-Score of 1.

Altman Z-Score	6.6
Piotroski F-Score	1